Kyoto Gene and Genome Encyclopedia (KEGG) enrichment revealed that the key targets of HL-RG in treating RCC were enriched in the proteoglycans in cancer, and the HIF-1 signaling pathway. Here, HIF1A is linked to renal cell carcinoma.